Nevada Medicaid and Nevada Check Up News (Third Quarter 2024 Provider Newsletter) [Read]

Attention Behavioral Health Providers: Monthly Behavioral Health Training Assistance (BHTA) Webinar Scheduled [See Web Announcement 2009]

Attention All Providers: Requirements on When to Use the National Provider Identifier (NPI) of an Ordering, Prescribing or Referring (OPR) Provider on Claims [Announcement 850]

If you are a Medicaid provider whose revalidation application has not been processed by your termination due date, you will be ineligible to provide services to any Nevada Medicaid or Nevada Check Up recipients, including both Fee-for-Service and Managed Care Organization (MCO) enrolled recipients. See Web Announcement 1265

Enrollment Termination Frequently Asked Questions (FAQs) [Review]

Notifications

Unwinding COVID-19 Information

Known System Issues-Click HERE

Paper claims are no longer accepted by Nevada Medicaid. Please refer to Web Announcement 1733 and Web Announcement 1829 for additional information.

Top 10 Claim Denial Reasons and Resolutions/Workarounds for November 2024 Professional Claims. See Web Announcement 3509.

Top Enrollment Return Reasons and Resolutions for January 2024 Submissions. See Web Announcement 3350.

Top Prior Authorization Denial Reasons for the Third Quarter of 2024. See Web Announcement 3488.

Attention Providers Using the Authorization Criteria Function: Results that return prior authorization (PA) requirements are accurate. For results that return “There are no records found based on the search criteria,” there may be a PA requirement if limits have been exceeded. To verify PA requirements, please refer to the Medicaid Services Manual (MSM) Chapter for your service type at dhcfp.nv.gov and the Billing Guide for your provider type at www.medicaid.nv.gov.

Scheduled Site Maintenance

During the scheduled site maintenance window the Provider Web Portal will be unavailable. The table below shows the regularly scheduled maintenance window. All times will be in the Pacific time zone.

Monday - Friday
12:00AM - 12:30AM

Monday
8:00PM - 12:00AM

Notice Date Title
Sept. 18, 2014 For Review at October 23 Meeting: Hepatitis C Polymerase Inhibitors
Sept. 18, 2014 For Review at October 23 Meeting: Immunomodulators
Sept. 18, 2014 For Review at October 23 Meeting: Long-Acting Opioids
Sept. 18, 2014 For Review at October 23 Meeting: Oral Anticoagulants
Aug. 11, 2014 For Review at August 13 Special Meeting: Proposed Criteria for Synagis® (Palivizumab)
July 23, 2014 For Review at July 24 Meeting: Agenda, Minutes, Utilization Data and Proposed Criteria
June 23, 2014 For Review at July 24 Meeting: Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
June 23, 2014 For Review at July 24 Meeting: Immunoglobulin E Monoclonal Antibodies
June 23, 2014 For Review at July 24 Meeting: Topical Acne Agents
March 11, 2014 For Review at April 24 Meeting: ADHD Agents and Stimulants
March 11, 2014 For Review at April 24 Meeting: Buprenorphine and Buprenorphine/Naloxone
March 11, 2014 For Review at April 24 Meeting: Hepatitis C Polymerase Inhibitors
March 11, 2014 For Review at April 24 Meeting: Hepatitis C Protease Inhibitors
March 11, 2014 For Review at April 24 Meeting: Immunomodulators
March 11, 2014 For Review at April 24 Meeting: Long-Acting Opioids
March 11, 2014 For Review at April 24 Meeting: Palivizumab
March 11, 2014 For Review at April 24 Meeting: Proton Pump Inhibitors
Jan. 17, 2014 For Review at January 23 Meeting: Agenda, Minutes, Utilization Data and Proposed Criteria

Return to Past Meeting Materials.